Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Profit After Tax (2009 - 2026)

Novartis Ag's (NVS) quarterly Profit After Tax came in at $3.3 billion in Q2 2026, down 19.06% year-over-year from $4.0 billion in Q2 2025, and up 3.2% quarter-over-quarter from $3.2 billion in Q1 2026.

Analysis

Novartis Ag (NVS) Profit After Tax (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Profit After Tax across 18 years of filings, most recently posting $3.3 billion for Q2 2026.

  • In Q2 2026, Profit After Tax fell 19.06% year-over-year to $3.3 billion; the TTM figure through Jun 2026 stood at $18.0 billion (down 9.84% YoY), while the FY2025 annual figure was $14.0 billion, up 16.99% from the prior year.
  • Profit After Tax came in at $3.3 billion for Q2 2026 at Novartis Ag, up from $3.2 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $9.1 billion in Q4 2024 to a low of $1.6 billion in Q3 2022.
  • Average Profit After Tax over 5 years is $3.9 billion, with a median of $3.2 billion recorded in 2024.
  • Year-over-year, Profit After Tax tumbled 66.34% in 2022 and surged 80.66% in 2024.
  • Over 5 years, Profit After Tax stood at $5.5 billion in 2022, then jumped by 54.49% to $8.5 billion in 2023, then rose by 7.54% to $9.1 billion in 2024, then retreated by 16.3% to $7.6 billion in 2025, then sank by 57.33% to $3.3 billion in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were $3.3 billion in Q2 2026, $3.2 billion in Q1 2026, and $7.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 5.53 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.62 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 3.26 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -248.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.40 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 438.21 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -644.37 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 237.01 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 585.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.26 Bn
Mar 31, 2026 3.16 Bn
Dec 31, 2025 7.63 Bn
Sep 30, 2025 3.93 Bn
Jun 30, 2025 4.02 Bn
Mar 31, 2025 3.61 Bn
Dec 31, 2024 9.12 Bn
Sep 30, 2024 3.19 Bn
Jun 30, 2024 3.25 Bn
Mar 31, 2024 2.69 Bn
Dec 31, 2023 8.48 Bn
Sep 30, 2023 1.76 Bn
Jun 30, 2023 2.32 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 5.49 Bn
Sep 30, 2022 1.58 Bn
Jun 30, 2022 1.70 Bn
Mar 31, 2022 2.22 Bn
Dec 31, 2021 16.31 Bn
Sep 30, 2021 2.76 Bn